These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38002270)

  • 1. Biological Effects of HDAC Inhibitors Vary with Zinc Binding Group: Differential Effects on Zinc Bioavailability, ROS Production, and R175H p53 Mutant Protein Reactivation.
    Flores BM; Uppalapati CK; Pascual AS; Vong A; Baatz MA; Harrison AM; Leyva KJ; Hull EE
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial Therapy of Zinc Metallochaperones with Mutant p53 Reactivation and Diminished Copper Binding.
    Zaman S; Yu X; Bencivenga AF; Blanden AR; Liu Y; Withers T; Na B; Blayney AJ; Gilleran J; Boothman DA; Loh SN; Kimball SD; Carpizo DR
    Mol Cancer Ther; 2019 Aug; 18(8):1355-1365. PubMed ID: 31196889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic metallochaperone ZMC1 rescues mutant p53 conformation by transporting zinc into cells as an ionophore.
    Blanden AR; Yu X; Wolfe AJ; Gilleran JA; Augeri DJ; O'Dell RS; Olson EC; Kimball SD; Emge TJ; Movileanu L; Carpizo DR; Loh SN
    Mol Pharmacol; 2015 May; 87(5):825-31. PubMed ID: 25710967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53.
    Yu X; Blanden A; Tsang AT; Zaman S; Liu Y; Gilleran J; Bencivenga AF; Kimball SD; Loh SN; Carpizo DR
    Mol Pharmacol; 2017 Jun; 91(6):567-575. PubMed ID: 28320780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule restoration of wildtype structure and function of mutant p53 using a novel zinc-metallochaperone based mechanism.
    Yu X; Blanden AR; Narayanan S; Jayakumar L; Lubin D; Augeri D; Kimball SD; Loh SN; Carpizo DR
    Oncotarget; 2014 Oct; 5(19):8879-92. PubMed ID: 25294809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc binding groups for histone deacetylase inhibitors.
    Zhang L; Zhang J; Jiang Q; Zhang L; Song W
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):714-721. PubMed ID: 29616828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of largazole zinc-binding group analogs.
    Kim B; Ratnayake R; Lee H; Shi G; Zeller SL; Li C; Luesch H; Hong J
    Bioorg Med Chem; 2017 Jun; 25(12):3077-3086. PubMed ID: 28416100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hydroxamate Zinc-Binding Groups as Warheads for Histone Deacetylases.
    Frühauf A; Meyer-Almes FJ
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Hydroxypyridin-2-thione as novel zinc binding group for selective histone deacetylase inhibition.
    Patil V; Sodji QH; Kornacki JR; Mrksich M; Oyelere AK
    J Med Chem; 2013 May; 56(9):3492-506. PubMed ID: 23547652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53.
    Mrakovcic M; Bohner L; Hanisch M; Fröhlich LF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altering relative metal-binding affinities in multifunctional Metallochaperones for mutant p53 reactivation.
    Kwan K; Castro-Sandoval O; Ma B; Martelino D; Saffari A; Liu XL; Orvain C; Mellitzer G; Gaiddon C; Storr T
    J Inorg Biochem; 2024 Feb; 251():112433. PubMed ID: 38043136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.
    Punganuru SR; Madala HR; Arutla V; Srivenugopal KS
    Carcinogenesis; 2018 Dec; 39(11):1399-1410. PubMed ID: 30010803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death.
    Mrakovcic M; Kleinheinz J; Fröhlich LF
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.
    Geurs S; Clarisse D; De Bosscher K; D'hooghe M
    J Med Chem; 2023 Jun; 66(12):7698-7729. PubMed ID: 37276138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.
    Puca R; Nardinocchi L; Porru M; Simon AJ; Rechavi G; Leonetti C; Givol D; D'Orazi G
    Cell Cycle; 2011 May; 10(10):1679-89. PubMed ID: 21508668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targeting of
    Na B; Yu X; Withers T; Gilleran J; Yao M; Foo TK; Chen C; Moore D; Lin Y; Kimball SD; Xia B; Ganesan S; Carpizo DR
    NPJ Breast Cancer; 2019; 5():14. PubMed ID: 30993195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.
    Shin HJ; DeCotiis J; Giron M; Palmeri D; Lukac DM
    J Virol; 2014 Jan; 88(2):1281-92. PubMed ID: 24227836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.